High incidence of injuries at the Pyeongchang 2018 Paralympic Winter Games: a prospective cohort study of 6804 athlete days.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Jan 2020
Historique:
accepted: 03 02 2019
pubmed: 24 2 2019
medline: 21 1 2020
entrez: 24 2 2019
Statut: ppublish

Résumé

To describe the epidemiology of sports injury at the Pyeongchang 2018 Paralympic Winter Games. 567 athletes from 49 countries were monitored daily for 12 days over the Pyeongchang 2018 Paralympic Winter Games (6804 athlete days). Injury data were obtained daily from teams with their own medical support (41 teams and 557 athletes) and teams without their own medical support (8 teams and 10 athletes) through two electronic data capturing systems. 112 of 567 athletes (19.8%) reported a total of 142 injuries, with an injury incidence rate (IR) of 20.9 per 1000 athlete days (95% CI 17.4 to 25.0). The highest IR was reported for para snowboard (IR of 40.5 per 1000 athlete days [95% CI 28.5 to 57.5]; p<0.02), particularly in the lower limb and head/face/neck anatomical areas. Across all sports at the Games, acute traumatic injuries (IR of 16.2 per 1000 athlete days [95% CI 13.2 to 19.8]) and injuries to the shoulder/arm/elbow complex (IR of 5.7 per 1000 athlete days [95% CI 4.2 to 7.8]) were most common. However, most injuries (78.9%) did not require time loss. The new Paralympic Winter Games sport of Para snowboard requires attention to implement actions that will reduce injury risk. The shoulder was the most injured single joint-a consistent finding in elite para sport.

Identifiants

pubmed: 30796104
pii: bjsports-2018-100170
doi: 10.1136/bjsports-2018-100170
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-43

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: All authors have declared competing interests.

Auteurs

Wayne Derman (W)

Institute of Sport and Exercise Medicine, Department of Surgical Sciences, Stellenbosch University, Cape Town, South Africa.
International Olympic Committee Research Centre, Cape Town, South Africa.

Phoebe Runciman (P)

Institute of Sport and Exercise Medicine, Department of Surgical Sciences, Stellenbosch University, Cape Town, South Africa.
International Olympic Committee Research Centre, Cape Town, South Africa.

Esme Jordaan (E)

Biostatistics Unit, Medical Research Council, Parow, South Africa.
Statistics and Population Studies Department, University of the Western Cape, Bellville, South Africa.

Martin Schwellnus (M)

Sport, Exercise Medicine and Lifestyle Institute (SEMLI), Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
IOC Research Centre, South Africa, Pretoria, South Africa.

Cheri Blauwet (C)

Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Nick Webborn (N)

Centre for Sport and Exercise Science and Medicine (SESAME), University of Brighton, Eastbourne, UK.

Jan Lexell (J)

Department of Neuroscience, Rehabilitation Medicine, Uppsala Universitet, Uppsala, Sweden.

Peter van de Vliet (P)

Medical and Scientific Department, International Paralympic Committee, Bonn, Germany.

James Kissick (J)

Carleton University Sport Medicine Clinic, Department of Family Medicine, University of Ottowa, Ottowa, Canada.

Jaap Stomphorst (J)

Department of Sports Medicine, Isala Klinieken, Zwolle, The Netherlands.

Young-Hee Lee (YH)

Rehabilitation Medicine, Wonju College of Medicine, Yonsei University, Wonju, Seoul, The Republic of Korea.

Keun-Suh Kim (KS)

Yonsei Institute of Sports Science and Exercise Medicine, Yonsei University, Seodaemun-gu, Seoul, The Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH